Equities

Vsee Health Inc

VSEE:NAQ

Vsee Health Inc

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)1.37
  • Today's Change0.05 / 3.79%
  • Shares traded23.77k
  • 1 Year change-89.16%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.

  • Revenue in USD (TTM)0.00
  • Net income in USD-3.49m
  • Incorporated2021
  • Employees0.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bebuzee Inc0.00-51.91k17.79m4.00---------0.0022-0.00220.00-0.0324---------------------------------100.00--92.80------
Arvana Inc25.05k-549.17k19.41m0.00------774.89-0.0051-0.00510.0002-0.01050.121-------265.27-5,329.73-----84.83---2,192.30-57,453.75---7.8710.06-------769.60------
Global Acquisitions Corp0.00-692.79k20.06m7.00---------0.0991-0.09910.00-0.00940.00-------865,987.50-5,181.61-------------------------21.68------
Thunder Power Holdings Inc0.00-2.70m20.44m----2.24-----0.0623-0.06230.000.12920.00-------37.74---74.10-------------9,981.110.1421-------320.28------
Yale Transaction Finders Inc0.00-42.11k20.74m0.00---------0.0081-0.00810.00-0.02180.00-------2,222.16-2,862.20---------------8.84--------43.69------
CONX Corp0.00-2.42m21.01m------7.63---0.1066-0.10660.00-0.75180.00-------4.46---4.80-------------5.04---------124.78------
Vsee Health Inc0.00-3.49m21.46m0.00---------0.9293-0.92930.00-3.320.00-------76.99-----------------5.61---------36.13------
Chesapeake Granite Wash Trust6.81m4.38m21.51m0.004.912.09--3.160.09380.09380.14570.22050.6565------42.2651.9542.2651.9593.3294.2264.3777.23----0.00100.00-32.50-4.56-38.04-6.56---6.16
Regency Affiliates Inc5.05m-5.06m22.15m2.00--0.3698--4.38-1.05-1.051.0512.440.0565--67.80---5.270.0106-5.440.010869.8568.33-93.230.2166--0.1660.2780---0.40057.415.34--47.453.07
Teton Advisors Inc11.48m1.14m22.72m22.0020.610.828615.451.980.70360.70367.0917.500.3826--13.55521,833.603.80-0.7134.07-0.920889.7888.609.92-1.31----0.00---12.58-15.68-24.72-11.60----
Freedom Internet Group Inc58.26k-337.05k22.82m--------391.71-0.0303-0.03030.00520.09090.0509-------29.45---29.76-------578.53------0.00---22.50---23.56------
Nvni Group Ltd-100.00bn-100.00bn23.46m507.00------------------------------------------------38.59---47.25------
Elah Holdings Inc12.00k-2.13m23.65m1.80k--3.03--1,970.92-2.88-3.000.016210.570.0013-------22.58-15.23-23.83-15.86-----17,716.67-3,322.83----0.00---23.81-30.6914.71------
Bexil Corp7.99m5.06m24.35m0.005.330.91514.733.057.507.5011.9243.710.3045--34.98--19.2910.8919.5111.11----63.3759.53----0.0095--1,629.97--278.75------
Nuveen Missouri Quality Mncpl Incm Fnd1.95m852.26k25.11m--29.460.933--12.890.36270.36270.829111.450.0424--12.78--1.85-0.11371.88-0.115738.6756.3143.74-2.93----0.412--4.52-1.27171.10-16.08---6.48
Data as of Nov 21 2024. Currency figures normalised to Vsee Health Inc's reporting currency: US Dollar USD

Institutional shareholders

5.09%Per cent of shares held by top holders
HolderShares% Held
SCS Capital Management LLCas of 20 Aug 2024502.50k3.27%
Ayrton Capital LLCas of 31 Dec 2023200.00k1.30%
Geode Capital Management LLCas of 30 Sep 202443.30k0.28%
Harrington Investments, Inc.as of 30 Sep 202414.34k0.09%
G1 Execution Services LLCas of 30 Sep 202413.15k0.09%
UBS Securities LLCas of 30 Sep 20248.66k0.06%
Bank of America, NA (Private Banking)as of 30 Sep 202446.000.00%
More ▼
Data from 30 Sep 2024 - 14 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.